shanchol

an oral vaccine derived from bivalent O1 and O139 strains without the CT B subunit

Networked: 19 relevant articles (3 outcomes, 8 trials/studies)

1.	Qadri, Firdausi: 8 articles (01/2022 - 10/2011)
2.	Chowdhury, Fahima: 5 articles (01/2022 - 10/2011)
3.	Ali, Mohammad: 4 articles (01/2019 - 10/2011)
4.	Luquero, Francisco J: 4 articles (11/2016 - 01/2013)
5.	Ryan, Edward T: 4 articles (10/2016 - 05/2014)
6.	Saha, Amit: 4 articles (05/2016 - 10/2011)
7.	Akter, Afroza: 3 articles (01/2022 - 05/2016)
8.	Clemens, John D: 3 articles (01/2022 - 05/2016)
9.	Kim, Deok Ryun: 3 articles (01/2022 - 02/2016)
10.	Ciglenecki, Iza: 3 articles (11/2016 - 01/2013)

1.	Cholera 11/01/2016 - "One dose of Shanchol was effective in preventing medically attended cholera in this study. " 05/29/2014 - "In this study, Shanchol was effective when used in response to a cholera outbreak in Guinea. " 03/10/2021 - "This study aimed to investigate the cost-effectiveness of the use of OCV Shanchol in response to a cholera outbreak in the Lake Chilwa area, Malawi. " 05/29/2014 - "The main objective of this study was to estimate the short-term effectiveness of two doses of Shanchol used as a part of the integrated response to a cholera outbreak in Africa. " 10/26/2011 - "The safety and immunogenicity data for Shanchol is promising and warrants future use in large scale trial in cholera endemic areas, high risk Bangladeshi population and in other countries in the region."
2.	HIV Infections (HIV Infection) 09/01/2015 - "Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection."